| Product Code: ETC9939838 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) C-Reactive Protein Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) C-Reactive Protein Market - Industry Life Cycle |
3.4 United Kingdom (UK) C-Reactive Protein Market - Porter's Five Forces |
3.5 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume Share, By Assay Type, 2021 & 2031F |
3.6 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume Share, By Detection Range, 2021 & 2031F |
3.7 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.8 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume Share, By Analysis Mode, 2021 & 2031F |
3.9 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume Share, By End- User, 2021 & 2031F |
3.10 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
4 United Kingdom (UK) C-Reactive Protein Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in the UK that require monitoring through c-reactive protein testing |
4.2.2 Growing awareness among healthcare professionals about the importance of early detection and monitoring of inflammatory conditions |
4.2.3 Technological advancements leading to the development of more sensitive and accurate c-reactive protein testing methods |
4.3 Market Restraints |
4.3.1 Stringent regulations governing the approval and commercialization of c-reactive protein testing kits in the UK |
4.3.2 Limited reimbursement policies for c-reactive protein testing, affecting adoption rates |
4.3.3 Competition from alternative biomarkers and diagnostic technologies impacting market growth |
5 United Kingdom (UK) C-Reactive Protein Market Trends |
6 United Kingdom (UK) C-Reactive Protein Market, By Types |
6.1 United Kingdom (UK) C-Reactive Protein Market, By Assay Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Assay Type, 2021- 2031F |
6.1.3 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Immunoturbidimetric Assay, 2021- 2031F |
6.1.4 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By ELISA, 2021- 2031F |
6.1.5 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Chemiluminescence Immunoassay, 2021- 2031F |
6.1.6 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) C-Reactive Protein Market, By Detection Range |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By hs-CRP, 2021- 2031F |
6.2.3 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Conventional CRP, 2021- 2031F |
6.2.4 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By cCRP, 2021- 2031F |
6.3 United Kingdom (UK) C-Reactive Protein Market, By Disease |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.3.5 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Inflammatory Bowel Disease, 2021- 2031F |
6.3.6 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Endometriosis, 2021- 2031F |
6.3.7 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Lupus, 2021- 2031F |
6.3.8 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F |
6.3.9 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F |
6.4 United Kingdom (UK) C-Reactive Protein Market, By Analysis Mode |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Serum, 2021- 2031F |
6.4.3 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Plasma, 2021- 2031F |
6.4.4 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Blood, 2021- 2031F |
6.5 United Kingdom (UK) C-Reactive Protein Market, By End- User |
6.5.1 Overview and Analysis |
6.5.2 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.5.5 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Assisted Living Healthcare Facilities, 2021- 2031F |
6.5.6 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Home, 2021- 2031F |
6.6 United Kingdom (UK) C-Reactive Protein Market, By Product Type |
6.6.1 Overview and Analysis |
6.6.2 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Kits, 2021- 2031F |
6.6.3 United Kingdom (UK) C-Reactive Protein Market Revenues & Volume, By Reagents, 2021- 2031F |
7 United Kingdom (UK) C-Reactive Protein Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) C-Reactive Protein Market Export to Major Countries |
7.2 United Kingdom (UK) C-Reactive Protein Market Imports from Major Countries |
8 United Kingdom (UK) C-Reactive Protein Market Key Performance Indicators |
8.1 Adoption rate of high-sensitivity c-reactive protein testing in clinical settings |
8.2 Number of research studies and publications highlighting the clinical utility of c-reactive protein testing |
8.3 Percentage of healthcare facilities offering c-reactive protein testing as part of routine diagnostics |
9 United Kingdom (UK) C-Reactive Protein Market - Opportunity Assessment |
9.1 United Kingdom (UK) C-Reactive Protein Market Opportunity Assessment, By Assay Type, 2021 & 2031F |
9.2 United Kingdom (UK) C-Reactive Protein Market Opportunity Assessment, By Detection Range, 2021 & 2031F |
9.3 United Kingdom (UK) C-Reactive Protein Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.4 United Kingdom (UK) C-Reactive Protein Market Opportunity Assessment, By Analysis Mode, 2021 & 2031F |
9.5 United Kingdom (UK) C-Reactive Protein Market Opportunity Assessment, By End- User, 2021 & 2031F |
9.6 United Kingdom (UK) C-Reactive Protein Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10 United Kingdom (UK) C-Reactive Protein Market - Competitive Landscape |
10.1 United Kingdom (UK) C-Reactive Protein Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) C-Reactive Protein Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here